EpiCast Report: Meningococcal Disease – Epidemiology Forecast to 2022

Publisher Name :
Date: 15-May-2013
No. of pages: 46

Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence of one to three cases per 100,000 population worldwide (Giuliani et al., 2006). Strains of Neisseria meningitidis are classified based on the chemical composition of unique polysaccharide capsules. Although there are 13 different serogroups, nearly all disease in humans is caused by strains representative of six serogroups: A, B, C, W-135, X and Y (CDC, 2012d; Halperin et al., 2012; Rosenstein et al., 2001). Humans are the only natural reservoir of Neisseria meningitidis, and the bacterium causes three common clinical forms of meningococcal disease: meningitis, blood infection, and pneumonia (CDC, 2012d; Wilder-Smith and Memish, 2003). Up to 10% of adolescents and adults are asymptomatic, transient carriers of the bacterium, which can be transmitted via respiratory droplets or by direct contact (CDC, 2012d).

During the forecast period, the number of incident cases will remain relatively stable. An increase in international travel to regions of high incidence could cause some serogroups to appear in countries where they were not previously prevalent. In addition to vaccinating international travelers, the vaccination of household members of individuals traveling to high-risk regions would further prevent outbreaks due to strains that certain populations are not yet immune to.

GlobalData epidemiologists obtained surveillance data for each market in this analysis, except for Spain and the UK. However, for these markets a peer-reviewed journal article was used that analyzed the surveillance data in these countries. The surveillance data used in this analysis are collected by country-specific, governmental organizations that routinely collect data on meningococcal disease cases. Use of surveillance data is optimal as it allows for a comprehensive picture of the epidemiology of the disease, including age and serogroup distribution. Although the overall incidence of meningococcal disease is relatively low, the age and serogroup segmentation of incident cases provided in this forecast shows the populations at highest risk for meningococcal disease in each market.

Scope

  • The Meningococcal Disease EpiCast Report provides an overview of the risk factors and global trends of meningococcal disease in the eight major markets (US, France, Germany, Italy, Spain, UK, Australia, and Brazil).
  • It includes a 10-year epidemiology forecast of meningococcal disease incident cases segmented by age (<1, 1–4, 5–14, 15–24, 25–44, 45–64, and ending at ages 65 years and older) and serogroup (B, C, Y, and W-135) in the 8MM.

Reasons To Buy

  • Develop business strategies by understanding the trends shaping and driving the global meningococcal disease market.
  • Quantify patient populations in the global meningococcal disease market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and serogroups that present the best opportunities for meningococcal disease vaccines in each of the markets covered.

EpiCast Report: Meningococcal Disease – Epidemiology Forecast to 2022

Table Of Contents

1 Table of Contents 4
List Of Tables 6
List Of Figures 6

2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Reports 8

3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.2.1 Infants and young children are at greatest risk for developing meningococcal disease 10
3.2.2 Direct contact and overcrowding are the primary risk factors for infection 11
3.2.3 Exposure is highest for those traveling to the African "meningitis belt" 12
3.3 Global Trends 13
3.3.1 US 13
3.3.2 5EU 14
3.3.3 Australia 15
3.3.4 Brazil 16
3.4 Forecast Methodology 17
3.4.1 Sources Used 19
3.4.2 Forecast Assumptions and Methods 23
3.4.3 Sources Not Used 27
3.5 Epidemiology Forecast of Meningococcal Disease (2012-2022) 28
3.5.1 Incident Cases of Meningococcal Disease 28
3.5.2 Age-Specific Incident Cases of Meningococcal Disease 30
3.5.3 Incident Cases of Meningococcal Disease By Serogroup 32
3.6 Discussion 34
3.6.1 Conclusions on Epidemiological Trends 34
3.6.2 Limitations of the Analysis 35
3.6.3 Strengths of the Analysis 35

4 Appendix 36
4.1 Bibliography 36
4.2 About the Authors 43
4.2.1 Epidemiologists 43
4.2.2 Reviewers 43
4.2.3 Global Director of Epidemiology and Clinical Trials Analysis 44
4.2.4 Global Head of Healthcare 44
4.3 About GlobalData 45
4.4 About EpiCast 45
4.5 Contact Us 45
4.6 Disclaimer 46

List Of Tables

Table 1: Risk Factors for Meningococcal Disease 10
Table 2: Sources of Incidence Data Used in the Epidemiology Forecast 18
Table 3: 8MM, Incident Cases of Meningococcal Disease, N, Select Years, 2012-2022 28
Table 4: 8MM, Incident Cases of Meningococcal Disease, By Age, N (Row %), 2012 31
Table 5: 8MM, Incident Cases of Meningococcal Disease, By Serogroup, N (Row %), 2012 32

List Of Figures

Figure 1: 8MM, Incident Cases of Meningococcal Disease, N, Select Years, 2012-2022 29
Figure 2: 8MM, Incident Cases of Meningococcal Disease, By Age, N, 2012 31
Figure 3: 8MM, Incident Cases of Meningococcal Disease, By Serogroup, %, 2012 33

  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Dengue – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Dengue - Pipeline Review, H1 2015', provides an overview of the Dengue's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therap......
  • Candidiasis – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Candidiasis - Pipeline Review, H1 2015', provides an overview of the Candidiasis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved ......
  • Chlamydia Trachomatis Infections – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Chlamydia Trachomatis Infections - Pipeline Review, H1 2015', provides an overview of the Chlamydia Trachomatis Infections's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chlamydia Trachomatis Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured......
  • Onychomycosis (Tinea Unguium) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2015', provides an overview of the Onychomycosis (Tinea Unguium)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Onychomycosis (Tinea Unguium), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and......
  • Ventilator Associated Pneumonia (VAP) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Ventilator Associated Pneumonia (VAP) - Pipeline Review, H1 2015', provides an overview of the Ventilator Associated Pneumonia (VAP)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ventilator Associated Pneumonia (VAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest update......
  • Helicobacter Pylori Infections – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Helicobacter Pylori Infections - Pipeline Review, H1 2015', provides an overview of the Helicobacter Pylori Infections's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ......
  • Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2015', provides an overview of the Elephantiasis (Lymphatic Filariasis)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Elephantiasis (Lymphatic Filariasis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, ......
  • Influenza B Infections – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Influenza B Infections - Pipeline Review, H1 2015', provides an overview of the Influenza B Infections's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Influenza B Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It a......
  • Nasopharyngitis (Common Cold) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Nasopharyngitis (Common Cold) - Pipeline Review, H1 2015', provides an overview of the Nasopharyngitis (Common Cold)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nasopharyngitis (Common Cold), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs